BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24575810)

  • 1. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
    Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
    BMC Cancer; 2014 Feb; 14():140. PubMed ID: 24575810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
    Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
    PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
    BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
    Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
    Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
    Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
    Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
    Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
    Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
    Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
    Yin ZM; Yu AJ; Wu MJ; Fang J; Liu LF; Zhu JQ; Yu H
    Eur J Gynaecol Oncol; 2015; 36(3):326-9. PubMed ID: 26189262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.
    Hoskins PJ; Swenerton KD; Pike JA; Lim P; Aquino-Parsons C; Wong F; Lee N
    J Clin Oncol; 2003 Sep; 21(18):3495-501. PubMed ID: 12972526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
    Okazawa-Sakai M; Yokoyama T; Fujimoto E; Okame S; Shiroyama Y; Yokoyama T; Takehara K
    Int J Clin Oncol; 2018 Aug; 23(4):715-725. PubMed ID: 29446043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
    Lissoni AA; Colombo N; Pellegrino A; Parma G; Zola P; Katsaros D; Chiari S; Buda A; Landoni F; Peiretti M; Dell'anna T; Fruscio R; Signorelli M; Grassi R; Floriani I; Fossati R; Torri V; Rulli E
    Ann Oncol; 2009 Apr; 20(4):660-5. PubMed ID: 19181826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen.
    Tokunaga H; Nagase S; Yoshinaga K; Tanaka S; Nagai T; Kurosawa H; Kaiho-Sakuma M; Toyoshima M; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Tohoku J Exp Med; 2013 Jan; 229(1):75-81. PubMed ID: 23269283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.